102 related articles for article (PubMed ID: 28670953)
1. The probable role of adrenomedullin and nitric oxide in childhood attention deficit hyperactivity disorder.
Gürbüz Özgür B; Aksu H; Yılmaz M; Karakoç Demirkaya S
Nord J Psychiatry; 2017 Oct; 71(7):521-524. PubMed ID: 28670953
[TBL] [Abstract][Full Text] [Related]
2. Iron Deficiency Parameters in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Percinel I; Yazici KU; Ustundag B
Child Psychiatry Hum Dev; 2016 Apr; 47(2):259-69. PubMed ID: 26092605
[TBL] [Abstract][Full Text] [Related]
3. Association between altered lipid profiles and attention deficit hyperactivity disorder in boys.
Avcil S
Nord J Psychiatry; 2018 Jul; 72(5):361-366. PubMed ID: 29688116
[TBL] [Abstract][Full Text] [Related]
4. [Attention deficit/hyperactivity disorder: burden of the disease according to subtypes in recently diagnosed children].
Escobar R; Hervas A; Soutullo C; Mardomingo MJ; Uruñuela A; Gilaberte I
Actas Esp Psiquiatr; 2008; 36(5):285-94. PubMed ID: 18830848
[TBL] [Abstract][Full Text] [Related]
5. Ubiquinone Levels as a Marker of Antioxidant System in Children with Attention Deficit Hyperactivity Disorder.
Karagöz YS; Doğan Ö; Elgün S; Öztop DB; Kılıç BG
J Mol Neurosci; 2021 Oct; 71(10):2173-2178. PubMed ID: 33245486
[TBL] [Abstract][Full Text] [Related]
6. Altered Arginine/Nitric Oxide Pathway in Children Diagnosed Attention Deficit Hyperactivity Disorder, and the Effect of 10 Weeks Methylphenidate Treatment.
Doneray E; Yazici KU; Yazici IP; Ustundag B
Clin Psychopharmacol Neurosci; 2022 May; 20(2):350-363. PubMed ID: 35466106
[TBL] [Abstract][Full Text] [Related]
7. Convergent and divergent validity of K-SADS-PL anxiety and attention deficit hyperactivity disorder diagnoses in a clinical sample of school-aged children.
Villabø MA; Oerbeck B; Skirbekk B; Hansen BH; Kristensen H
Nord J Psychiatry; 2016 Jul; 70(5):358-64. PubMed ID: 26836986
[TBL] [Abstract][Full Text] [Related]
8. Effects of adenoidectomy/adenotonsillectomy on ADHD symptoms and behavioral problems in children.
Aksu H; Günel C; Özgür BG; Toka A; Başak S
Int J Pediatr Otorhinolaryngol; 2015 Jul; 79(7):1030-3. PubMed ID: 25933698
[TBL] [Abstract][Full Text] [Related]
9. Oxidative imbalance in adult attention deficit/hyperactivity disorder.
Selek S; Savas HA; Gergerlioglu HS; Bulut M; Yilmaz HR
Biol Psychol; 2008 Oct; 79(2):256-9. PubMed ID: 18644422
[TBL] [Abstract][Full Text] [Related]
10. Thyroid and Cortisol hormones in Attention Deficit Hyperactivity Disorder: A case-control study.
Kuppili PP; Pattanayak RD; Sagar R; Mehta M; Vivekanandhan S
Asian J Psychiatr; 2017 Aug; 28():73-77. PubMed ID: 28784401
[TBL] [Abstract][Full Text] [Related]
11. Possible role of adrenomedullin and nitric oxide in major depression.
Akpinar A; Yaman GB; Demirdas A; Onal S
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Oct; 46():120-5. PubMed ID: 23867466
[TBL] [Abstract][Full Text] [Related]
12. Bipolar disorder co-morbidity in children with attention deficit hyperactivity disorder.
Donfrancesco R; Miano S; Martines F; Ferrante L; Melegari MG; Masi G
Psychiatry Res; 2011 Apr; 186(2-3):333-7. PubMed ID: 20692046
[TBL] [Abstract][Full Text] [Related]
13. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder.
Smalley SL; McGough JJ; Del'Homme M; NewDelman J; Gordon E; Kim T; Liu A; McCracken JT
J Am Acad Child Adolesc Psychiatry; 2000 Sep; 39(9):1135-43. PubMed ID: 10986810
[TBL] [Abstract][Full Text] [Related]
14. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
Klassen AF; Miller A; Fine S
Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric comorbidity in Korean children and adolescents with attention-deficit hyperactivity disorder: psychopathology according to subtype.
Byun H; Yang J; Lee M; Jang W; Yang JW; Kim JH; Hong SD; Joung YS
Yonsei Med J; 2006 Feb; 47(1):113-21. PubMed ID: 16502492
[TBL] [Abstract][Full Text] [Related]
16. Hormone disorder and vitamin deficiency in attention deficit hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs).
Bala KA; Doğan M; Kaba S; Mutluer T; Aslan O; Doğan SZ
J Pediatr Endocrinol Metab; 2016 Sep; 29(9):1077-82. PubMed ID: 27544717
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal trajectories of ADHD symptomatology in offspring of parents with bipolar disorder and community controls.
Kim JW; Yu H; Ryan ND; Axelson DA; Goldstein BI; Goldstein TR; Diler RS; Monk K; Hickey MB; Sakolsky DJ; Merranko JA; Birmaher B
J Clin Psychiatry; 2015 May; 76(5):599-606. PubMed ID: 26035189
[TBL] [Abstract][Full Text] [Related]
18. Atomoxetine response in the inattentive and combined subtypes of attention deficit hyperactivity disorder: a retrospective chart review.
Ercan ES; Akyol Ardic U; Kabukcu Basay B; Ercan E; Basay O
Atten Defic Hyperact Disord; 2013 Dec; 5(4):377-85. PubMed ID: 23737214
[TBL] [Abstract][Full Text] [Related]
19. Comorbidity of attention-deficit/hyperactivity disorder and bipolar disorder in North Indian clinic children and adolescents.
Sivakumar T; Agarwal V; Sitholey P
Asian J Psychiatr; 2013 Jun; 6(3):235-42. PubMed ID: 23642982
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y Levels in Children and Adolescents with Attention Deficit Hyperactivity Disorder.
Hekim Bozkurt Ö; Güney E; Göker Z; Şenses Dinç G; Alışık M; Erel Ö; Çöp E; Üneri ÖŞ
Turk Psikiyatri Derg; 2018; 29(1):31-35. PubMed ID: 29730872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
